Literature DB >> 8608573

Telomere changes in human hepatocellular carcinomas and hepatitis virus infected noncancerous livers.

K Ohashi1, M Tsutsumi, Y Nakajima, K Kobitsu, H Nakano, Y Konishi.   

Abstract

BACKGROUND: Telomeres, at the ends of eukaryotic chromosomes, are defined functionally as necessary for chromosome stability. Chromosome instability induced in part by loss of telomeric DNA has been considered to play a significant role in the development of human cancers. However, little is known about the status of telomeres per se during human hepatocellular carcinoma (HCC) development.
METHODS: The study was conducted to determine the length of terminal restriction fragments (TRFs) at the telomeric ends in 23 HCCs and 23 corresponding noncancerous liver tissues from the same patients harboring hepatitis virus infections, and in 5 samples of noncancerous livers without the hepatitis virus. The latter samples had been obtained as controls at surgery for metastatic liver tumors.
RESULTS: All 23 HCCs demonstrated reduction in TRF length compared with the corresponding noncancerous liver tissues with viral infection. The TRF in the latter cases also demonstrated a significant shortening as compared with the virus free control tissue, the degree being calculated to represent an average of 42 cell divisions. Reduction in TRF length in HCC samples tended to increase with the tumor diameter, although this failed to show statistical significance.
CONCLUSIONS: These results indicate that telomere shortening occurs during HCC development. The fact that this change is already evident in noncancerous liver tissues from patients with viral hepatitis suggests that it may play an important role in the associated generation of tumors.

Entities:  

Mesh:

Year:  1996        PMID: 8608573     DOI: 10.1002/(SICI)1097-0142(19960415)77:8<1747::AID-CNCR50>3.0.CO;2-W

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Telomerase activity-independent function of TERT allows glioma cells to attain cancer stem cell characteristics by inducing EGFR expression.

Authors:  Samuel Beck; Xun Jin; Young-Woo Sohn; Jun-Kyum Kim; Sung-Hak Kim; Jinlong Yin; Xumin Pian; Sung-Chan Kim; Do-Hyun Nam; Yun-Jaie Choi; Hyunggee Kim
Journal:  Mol Cells       Date:  2010-12-24       Impact factor: 5.034

2.  Telomerase activity in hepatocellular carcinoma as a predictor of postoperative recurrence.

Authors:  K Ohta; T Kanamaru; Y Morita; Y Hayashi; H Ito; M Yamamoto
Journal:  J Gastroenterol       Date:  1997-12       Impact factor: 7.527

3.  Exosomal tRF-Leu-AAG-001 derived from mast cell as a potential non-invasive diagnostic biomarker for endometriosis.

Authors:  Yingxue Li; Shuling Cui; Zemin Xu; Yanping Zhang; Tao Wu; Jing Zhang; Yichen Chen
Journal:  BMC Womens Health       Date:  2022-06-25       Impact factor: 2.742

Review 4.  The role of telomeres and telomerase in cirrhosis and liver cancer.

Authors:  Jean-Charles Nault; Massih Ningarhari; Sandra Rebouissou; Jessica Zucman-Rossi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-06-28       Impact factor: 46.802

5.  Telomere Length and Survival of Patients with Hepatocellular Carcinoma in the United States.

Authors:  Baiyu Yang; Fatma M Shebl; Lawrence R Sternberg; Andrew C Warner; David E Kleiner; Daniel C Edelman; Allison Gomez; Casey L Dagnall; Belynda D Hicks; Sean F Altekruse; Brenda Y Hernandez; Charles F Lynch; Paul S Meltzer; Katherine A McGlynn
Journal:  PLoS One       Date:  2016-11-23       Impact factor: 3.240

6.  Increased telomerase activity in hyperplastic nodules and hepatocellular carcinomas induced by a choline-deficient L-amino acid-defined diet in rats.

Authors:  T Tsujiuchi; M Tsutsumi; A Kido; K Kobitsu; M Takahama; T Majima; A Denda; D Nakae; Y Konishi
Journal:  Jpn J Cancer Res       Date:  1996-11

7.  Surgical significance of telomerase activity in noncancerous liver tissue from patients with hepatocellular carcinoma.

Authors:  T Kanamaru; Y Morita; T Itoh; M Yamamoto; Y Kuroda; H Hisatomi
Journal:  Jpn J Cancer Res       Date:  1998-07

Review 8.  MDM2-p53 Interactions in Human Hepatocellular Carcinoma: What Is the Role of Nutlins and New Therapeutic Options?

Authors:  Samy A Azer
Journal:  J Clin Med       Date:  2018-03-27       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.